Found 72 clinical trials
MRCT Evaluating NCX 470 vs. Latanoprost in Subjects With Open-Angle Glaucoma or Ocular Hypertension (Denali)
-angle glaucoma. Subjects will be randomized in a 1:1 ratio to NCX 470 0.1% or to latanoprost 0.005% to be administered to both eyes once daily in the evening for up to 12 months.
- 0 views
- 10 May, 2022
- 1 location
Evaluation of the Duration of Effect of Bimatoprost SR in Participants With Open-Angle Glaucoma or Ocular Hypertension
This study evaluates the duration of intraocular pressure (IOP)-lowering effect and safety of as needed administrations of Bimatoprost sustained release (SR) in participants with open-angle
- 401 views
- 25 May, 2022
- 90 locations
Clinical Study Comparing Two Models of a Travoprost Intraocular Implant
reducing elevated intraocular pressure in subjects with open angle glaucoma (OAG) or ocular hypertension (OHT)
- 0 views
- 10 May, 2021
- 1 location
The Glaucoma Nicotinamide Trial (TGNT)
the Vitamin B3 In Glaucoma Study (VBIGS). Patients with open-angle glaucoma (OAG) will be randomized to receive either Nicotinamide or placebo through block randomization stratified by glaucoma
- 0 views
- 19 Jun, 2022
- 2 locations
Providing Financial Incentives to Improve Adherence to Referral Eye Care Visits
Glaucoma is a blinding eye disease increasingly common in older adults, particularly in African Americans, and often diagnosed late in the disease course. It is essential to develop novel health care models, utilizing telemedicine, to improve the ability to detect glaucoma at an earlier stage, and to provide a platform …
- 0 views
- 22 Apr, 2022
- 1 location
PRO-122 Versus Concomitant Therapy in Subjects With Uncontrolled Primary Open-angle Glaucoma (PRO-122LATAM)
concomitant therapy in subjects with uncontrolled primary open-angle glaucoma and/or IOP. Hypothesis: The mean (average) value of the IOP final absolute reduction in the experimental group (PRO-122
- 40 views
- 02 Jan, 2022
- 2 locations
GlaucoT Glaucoma Treatment Glasses in the Treatment of Primary Open-Angle Glaucoma (GlaucoT)
second cause of preventable blindness in the world, affects nearly 60 million people worldwide. The most common type of glaucoma is primary open-angle glaucoma (POAG). POAG is a chronic
- 0 views
- 14 Apr, 2022
Effect of Acupuncture on Visual Acuity and Visual Field in Patients With Primary Open-angle Glaucoma
patients with primary open-angle glaucoma. This study designed a randomized, single-blind, controlled clinical trial. A total of 40 patients with primary open-angle glaucoma were randomly divided into two
- 0 views
- 15 Mar, 2022
- 1 location
A Novel Argon Laser Iridoplasty for Pigment Dispersion Syndrome
Pigment dispersion syndrome is a rare condition where anomalous iris configuration leads to posterior iris bowing with subsequent friction with the lenticulozonular unit resulting in dispersion
- 0 views
- 24 Mar, 2022
- 1 location
Effect of Metformin on Visual Function in Patients With Glaucoma
The purpose of this study is to determine whether Metformin could prevent the progression of glaucoma in a safe and effective manner.
- 6 views
- 25 Mar, 2022
- 1 location